Distinguishing Menière's Disease from Acute Peripheral Vertigo
Menière's disease is a specific subtype of peripheral vertigo characterized by the triad of recurrent vertigo attacks lasting 20 minutes to 12 hours, fluctuating low-to-mid frequency sensorineural hearing loss, and fluctuating aural symptoms (tinnitus, ear fullness), whereas acute peripheral vertigo is a broader category encompassing multiple conditions with distinct temporal patterns and associated features. 1
Key Diagnostic Distinctions
Duration of Vertigo Episodes
The duration of vertigo is the single most important distinguishing feature:
- Menière's disease: Episodes last 20 minutes to 12 hours by definition 1, 2
- BPPV (most common acute peripheral vertigo): Episodes last seconds to less than 1 minute, triggered by specific head position changes 1, 3
- Vestibular neuritis: Single prolonged episode lasting days to weeks (12-36 hours of severe rotational vertigo, followed by 4-5 days of decreasing disequilibrium) 1
- Labyrinthitis: Sudden severe vertigo lasting more than 24 hours with profound hearing loss 1
Associated Auditory Symptoms
Menière's disease is distinguished by its characteristic fluctuating hearing pattern:
- Menière's disease: Audiometrically documented fluctuating low-to-mid frequency sensorineural hearing loss in the affected ear, with tinnitus and aural fullness that fluctuate with attacks 1, 4
- BPPV: No hearing loss, tinnitus, or aural fullness 1, 5
- Vestibular neuritis: No hearing loss, tinnitus, or aural fullness 1
- Labyrinthitis: Profound hearing loss that does not fluctuate and is typically permanent 1
Temporal Pattern of Attacks
The pattern of recurrence differs significantly:
- Menière's disease: Recurrent spontaneous attacks occurring over months to years, with at least two documented episodes required for diagnosis 1, 6
- BPPV: Triggered episodes only with specific head movements (Dix-Hallpike positive), not spontaneous 1, 3
- Vestibular neuritis: Typically a single monophasic event, though some patients may have recurrence 1
Diagnostic Workup Differences
For Suspected Menière's Disease
Confirm true vertigo (rotational spinning sensation) rather than vague dizziness, as many patients use imprecise terminology 1, 2
Obtain comprehensive audiometry to document:
- Low-to-mid frequency sensorineural hearing loss pattern 1
- Fluctuation in hearing thresholds (may require serial audiograms) 1, 4
- Pure tone average and word recognition scores 1
Consider MRI of the brain and internal auditory canals with and without contrast for:
- Unilateral or pulsatile tinnitus to exclude vestibular schwannoma 3
- Asymmetric hearing loss 3
- Atypical presentation requiring definitive diagnosis 3
Electrocochleography may show elevated summating potential/action potential ratio, though this is not required for diagnosis 1
For Suspected Acute Peripheral Vertigo (Non-Menière's)
Perform Dix-Hallpike maneuver bilaterally for BPPV diagnosis, looking for:
- Latency period of 5-20 seconds 3, 5
- Torsional upbeating nystagmus toward the affected ear 3
- Vertigo and nystagmus that increase then resolve within 60 seconds 3
No imaging or vestibular testing is needed for typical BPPV with positive Dix-Hallpike and no red flags 3
For acute persistent vertigo (vestibular neuritis), perform HINTS examination (when trained) to exclude stroke:
- Normal head impulse test suggests central cause 3
- Direction-changing or vertical nystagmus suggests central cause 3
- Present skew deviation suggests central cause 3
Critical Red Flags Requiring Urgent Neuroimaging
These features mandate immediate MRI brain without contrast to exclude stroke, even in presumed peripheral vertigo:
- Focal neurological deficits on examination 3, 5
- Sudden unilateral hearing loss 3, 5
- Inability to stand or walk 3, 5
- Downbeating nystagmus or other central nystagmus patterns 3, 5
- New severe headache accompanying dizziness 3
- High vascular risk factors (age >50, hypertension, diabetes, prior stroke) with acute vestibular syndrome 3
Management Approach Differences
Menière's Disease Management
Dietary and lifestyle modifications as first-line therapy:
- Sodium restriction to 1500-2300 mg/day maximum 2
- Limit caffeine, alcohol, and nicotine 2
- Adequate hydration with water 2
- Stress management through sleep, exercise, meditation 2
Medical management for persistent symptoms:
- Diuretics (though evidence is limited) 1, 7
- Betahistine (commonly used in Europe) 1, 7
- Oral steroids for acute attacks 1
Intratympanic gentamicin for refractory vertigo when medical management fails 1, 6, 7
Endolymphatic sac decompression surgery for patients who fail conservative and medical management 1
Acute Peripheral Vertigo (BPPV) Management
Canalith repositioning procedures (Epley maneuver) as first-line treatment:
- 80% success rate after 1-3 treatments 3, 5
- 90-98% success with repeat maneuvers if initial treatment fails 3, 5
- No medications needed for typical BPPV 3
Reassess within one month to document resolution or persistence 3
Vestibular rehabilitation therapy for persistent dizziness after initial treatment 3
Vestibular Neuritis Management
Vestibular suppressants (antiemetics, benzodiazepines) for acute phase only 1
Early vestibular rehabilitation therapy to promote central compensation 1
Corticosteroids may be considered in the acute phase, though evidence is mixed 7
Common Diagnostic Pitfalls
Do not rely on patient descriptions of "spinning" versus "lightheadedness"—focus instead on timing, triggers, and associated symptoms 1, 3
Vestibular migraine can mimic Menière's disease with similar duration attacks (minutes to hours), but typically lacks fluctuating hearing loss 1, 8
35% of Menière's patients also meet criteria for vestibular migraine, creating diagnostic overlap 3
Elderly patients with long-standing Menière's may present with vague dizziness rather than frank vertigo 1
75-80% of patients with posterior circulation stroke have no focal neurologic deficits, making stroke easy to miss in acute vestibular syndrome 5
Assuming normal neurologic exam excludes stroke is incorrect—use HINTS examination or obtain MRI in high-risk patients 3, 5